These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35372112)

  • 21. Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3.
    Fedak PW; Altamentova SM; Weisel RD; Nili N; Ohno N; Verma S; Lee TY; Kiani C; Mickle DA; Strauss BH; Li RK
    Am J Physiol Heart Circ Physiol; 2003 Feb; 284(2):H626-34. PubMed ID: 12388270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression and localization of selected matrix metalloproteinases (MMP-2, -7 and -9) and their tissue inhibitors (TIMP-2 and -3) in follicular cysts of sows.
    Grzesiak M; Kaminska K; Knapczyk-Stwora K; Hrabia A
    Theriogenology; 2022 Jun; 185():109-120. PubMed ID: 35395587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential gene expression of extracellular matrix components in dilated cardiomyopathy.
    Tyagi SC; Kumar S; Voelker DJ; Reddy HK; Janicki JS; Curtis JJ
    J Cell Biochem; 1996 Nov; 63(2):185-98. PubMed ID: 8913870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of eCG treatment on gene expression of selected matrix metalloproteinases (MMP-2, MMP-7, MMP-9, MMP-10, and MMP-13) and the tissue inhibitors of metalloproteinases (TIMP-2 and TIMP-3) in the chicken ovary.
    Wolak D; Sechman A; Hrabia A
    Anim Reprod Sci; 2021 Jan; 224():106666. PubMed ID: 33260067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
    Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W
    Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis.
    Tanaka K; Essick EE; Doros G; Tanriverdi K; Connors LH; Seldin DC; Sam F
    J Am Heart Assoc; 2013 Mar; 2(2):e005868. PubMed ID: 23537813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
    Spinale FG; Coker ML; Bond BR; Zellner JL
    Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.
    Spinale FG; Coker ML; Heung LJ; Bond BR; Gunasinghe HR; Etoh T; Goldberg AT; Zellner JL; Crumbley AJ
    Circulation; 2000 Oct; 102(16):1944-9. PubMed ID: 11034943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat.
    Curry TE; Song L; Wheeler SE
    Biol Reprod; 2001 Sep; 65(3):855-65. PubMed ID: 11514351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction.
    Mukherjee R; Snipes JM; Saunders SM; Zavadzkas JA; Spinale FG
    J Surg Res; 2012 Jan; 172(1):59-67. PubMed ID: 20863528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Aging of the myocardium and dilated cardiomyopathy: morphological and molecular aspects].
    Antonov IB; Kozlov KL; Linkova NS; Paltseva EM; Kykanova EO
    Adv Gerontol; 2017; 30(2):282-290. PubMed ID: 28575570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
    Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
    J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
    Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
    Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis.
    Cheung C; Luo H; Yanagawa B; Leong HS; Samarasekera D; Lai JC; Suarez A; Zhang J; McManus BM
    Cardiovasc Pathol; 2006; 15(2):63-74. PubMed ID: 16533694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical study of matrix metalloproteinases-2 and -9, macrophage inflammatory protein-2 and tissue inhibitors of matrix metalloproteinases-1 and -2 in normal, purulonecrotic and fungal infected equine corneas.
    Boveland SD; Moore PA; Mysore J; Krunkosky TM; Dietrich UM; Jarrett C; Paige Carmichael K
    Vet Ophthalmol; 2010 Mar; 13(2):81-90. PubMed ID: 20447025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy.
    Tziakas DN; Chalikias GK; Papaioakeim M; Hatzinikolaou EI; Stakos DA; Tentes IK; Papanas N; Kortsaris A; Maltezos E; Hatseras DI
    Am J Cardiol; 2005 Nov; 96(10):1449-51. PubMed ID: 16275197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease.
    Medeiros NI; Fares RC; Franco EP; Sousa GR; Mattos RT; Chaves AT; Nunes MD; Dutra WO; Correa-Oliveira R; Rocha MO; Gomes JA
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005284. PubMed ID: 28118356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of matrix metalloproteinase-9 (MMP-9) expression in the myocardium of congestive heart failure patients.
    Batlle M; Pérez-Villa F; García-Pras E; Lázaro A; Orús J; Roqué M; Roig E
    Transplant Proc; 2007 Sep; 39(7):2344-6. PubMed ID: 17889183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1 and TIMP-2 in the epithelium and stroma of salivary gland pleomorphic adenomas.
    Zhang X; Wang Y; Yamamoto G; Tachikawa T
    Histopathology; 2009 Sep; 55(3):250-60. PubMed ID: 19723139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.